European Commission gives thumbs up to Novo Holdings' $16.5 billion acquisition of contract manufacturer Catalent

FTC still reviewing

Companies expect deal to close by New Year's

Other pharma executives, like Lilly and Roche CEOs, have publicly voiced concerns about the deal's impact